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Background: Parathyroid metastatic disease from thyroid cancer has not been studied extensively, mainly due to
the need for parathyroid preservation during thyroid surgery.
Methods: We reviewed files from 1,770 patients with thyroid cancer followed up in our department and 10
patients with parathyroid metastases (0.5%) were identified. Patient and tumor characteristics were recorded.
Results: Six out of ten patients had metastases from papillary thyroid cancer, three from follicular thyroid cancer
and one from anaplastic thyroid cancer. In nine patients parathyroid infiltration from thyroid cancer was found in
direct contact with the thyroid cancer, and in one patient metastatic foci were observed not in continuity with the
thyroid cancer.
Conclusions: Parathyroid involvement, although infrequent, may occur in thyroid cancer independently of patient
age and tumor size. The clinical significance of such event is not clear. The influence on disease outcome remains
to be elucidated.
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The parathyroid glands are rare metastatic sites from dif-
ferent cancers such as bronchogenic carcinomas, leukemia,
thyroid and breast cancers [1] and the earlier reports
regarding parathyroid involvement included cases from
postmortem series [2]. Largely, the incidence of parathy-
roid metastatic disease in thyroid cancer is unknown, since
infiltration of the parathyroid glands is not sought during
surgery, even in invasive tumors, and published data on
parathyroid involvement in thyroid cancer are scant. A few
reports on parathyroid invasion or metastases from thyroid
cancer exist only for papillary thyroid cancer (PTC) [3].
Parathyroid metastatic disease in thyroid cancer may
occur via two different pathways. Most commonly the
tumor infiltrates the thyroid capsule and invades the para-
thyroid due to direct contact; less often a hematogenous
spread occurs and metastatic foci appear in the parathyroid
gland [4].* Correspondence: kpazaitou@in.gr
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distribution, and reproduction in any mediumWe aimed to select those cases from our cohort
patients with thyroid cancer that had parathyroid infil-
tration. We recognized parathyroid metastases in PTC,
follicular thyroid cancer (FTC) and anaplastic thyroid
cancer patients. As reports do not exist for parathyroid
involvement in FTC, we described in more detail the
characteristics of these cases.Methods
All files from thyroid cancer patients (1,770 in total)
followed up at the Department of Endocrinology &
Endocrine Oncology in Theagenio Cancer Hospital of
Thessaloniki, Greece, were retrospectively reviewed. Ten
patients with parathyroid involvement were identified
from the histological reports. Clinicopathological data
including sex, age at diagnosis, size and histological type,
tumoral characteristics and extent of metastatic disease of
thyroid cancer were recorded for every patient. The study
was approved by the Institutional Review Board.
Parathyroid involvement was defined as the infiltration of
the thyroid tumor into the parathyroid gland, in the pres-
ence or absence of direct invasion from the primary tumor.ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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fixed in formaldehyde 10%, multiple areas of the gland,
tumor and capsule were sampled, embedded in paraffin
and cut in 4 μ width sections. Staining methods were
H&E and immunohistochemistry with thyroid transcrip-
tion factor-1.
Results
In our cohort of 1,770 patients with thyroid cancer, 254
had histologically proven parathyroid removal at the time
of thyroidectomy (in 225 a single parathyroid gland was
removed and in 29 patients two parathyroid glands were
removed). As a result, the frequency of parathyroid in-
volvement from thyroid cancer among cases that parathy-
roid were excised was 3.94% (10 out of 254 cases). In total
the frequency of parathyroid involvement in thyroidecto-
mised patients was 0.5% (10 out of 1770 patients).
Six patients were identified with parathyroid involve-
ment from PTC, three from FTC and one from anaplastic
thyroid cancer. Clinical and histological characteristics are
shown in Table 1. The mode of involvement was invasion
to the parathyroid gland from the adjacent thyroid cancer
in nine cases and metastasis to the parathyroid gland in
one case with FTC. The size of the primary thyroid tumor
had a median diameter of 2.5 (range 1 to 5) cm. In the
nine cases with parathyroid invasion, extrathyroidal exten-
sion to soft tissues was also identified, as shown in Table 1.
None of the patients presented with extrathyroidal exten-
sion to trachea, oesophagus or jugular vein.
Eight out of ten patients had focal infiltration (≤50% of
the parathyroid gland) rather than involvement of the
entire gland (which was seen in two patients). In nine
patients only one parathyroid was excised and the
remaining patient had two glands removed, oneTable 1 Clinical and histological characteristics of the
patients










1* 62 f IV FTC F, V, M no L, B 7
2 57 f III FTC C, V no no 10
3 55 f III FTC C no no 4.5
4 56 m III PTC C yes no 3
5 42 f I PTC C, F yes no 2.5
6 71 f III PTC C, F, N, M yes no 1
7 17 m II PTC C, F, N, M yes L 1
8 18 f I PTC C, F no no 11
9 68 f III PTC C, F, N, M no no 1
10 76 f IV ATC C, F, N, M yes no 1
TC, thyroid cancer; LN, lymph node; f, female, m, male; FTC, follicular thyroid
cancer; PTC, papillary thyroid cancer; ATC, anaplastic thyroid cancer; F, fat
tissue; V, vessels; M, muscle; C, thyroid capsule; N, nerves; L, lung; B, brain.
*Patient 1 is deceased because of brain metastases.infiltrated and one normal parathyroid gland. In all
patients one metastatic parathyroid gland was found. In
the reported cases, parathyroid glands were removed
mostly accidentally during thyroidectomy.
Due to differences in clinical outcome, and despite the
small sample size, the cases of FTC and PTC were
reviewed separately. All the PTC patients with parathy-
roid involvement had invasion of the thyroid capsule,
and in 70% of patients lymph node metastases were also
found. In the three FTC patients, however, lymph node
metastases were not observed, but all demonstrated
extrathyroidal extension. Four out of six PTC patients,
but none of the FTC patients, had multifocal tumors.
The histological features of two out of three cases with
FTC are shown in Figures 1, 2, 3 and 4. Lung metastases
developed in a 17-year-old male with PTC and one FTC
patient (who also developed brain metastases during
follow-up). The patient with the anaplastic thyroid can-
cer was a 75-year-old female with locally invasive tumor
and parathyroid, lymph node and vessel infiltration.
Post-surgical median (range) serum calcium levels
were 9 (7.3 to 10) mg/dl. Transient hypoparathyroidismFigure 1 H&E stained section of affected parathyroid gland
(x100). A parathyroid gland is shown, invaded from a follicular thyroid
carcinoma. Malignant cells are large, composed of eosinophilic
cytoplasm and round nuclei. These tumor cells form groups or scant
follicles with parathyroid cells and lipocytes among them. At the
periphery of this picture the parathyroid capsule is shown.
Figure 2 Positive immunohistochemical staining of the
parathyroid gland (shown in Figure 1) for thyroid transcription
factor-1. Tumor cells have dark nuclei while parathyroid cells are
negative with clear cytoplasm.
Figure 3 Low power picture of an H&E stained section of the
parathyroid with an intraparenchymal metastasis. The lobe of
the thyroid is infiltrated by a well demarcated, irregularly
circumscribed, multinodular, solid, tan neoplasm with microscopic
characteristics of poorly differentiated follicular carcinoma, which
shows extensive vascular invasion. A grossly identified parathyroid
on the surface of the lobe shows infiltration by the carcinoma, not
in direct continuity with the tumor of the thyroid. This is a 500 μm
calibrated picture.
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hypoparathyroidism was seen in one patient, treated
with calcium and vitamin D supplementation.
Discussions
The parathyroid involvement is an uncommon event in
patients with thyroid cancer. In PTC, incidence rates of
1.6 to 2.2% are reported [3;4]. Among patients with his-
tologically proven parathyroid examination after thyroi-
dectomy, the rate of parathyroid involvement is much
higher (7.9%) [5]. From our cohort, the frequency of
parathyroid involvement is very low (0.5%), and among
cases with removed parathyroid glands is 3.95% as only
a few patients had parathyroid removal at the time of
thyroid surgery. Probably this frequency does not reflect
the true parathyroid involvement. In surgical practice,
even when extensive surgery is planned for a patient
with thyroid cancer, special attention is paid to the pres-
ervation of parathyroid glands. As a result, the presence
of parathyroid involvement identified during thyroidect-
omy is probably underestimated and the true extent is
unknown. Parathyroid invasion has been associated with
advanced stage of disease and lung metastases in older
male patients [5]. Invasion of adjacent structures wasseen in all our patients, in accordance with previous
reports. However, old age was not a significant factor in
our cases, as two patients were 17 and 18 years old at
the time of diagnosis.
Published data up to now originated only from Japan
[3-5]. There are no European or American reports, ex-
cept from isolated reports [6], to identify the extent of
this phenomenon in other populations and to seek pos-
sible regional differences. Therefore, the current staging
system for differentiated thyroid cancer does not include
the parathyroid as a metastatic site [7], possibly due to
the rarity of the event.
In all our patients, only one parathyroid gland was
found affected in the histological material. Therefore, the
presence of micro-metastases in the remaining glands is
possible. Microscopic residual disease in advanced thyroid
cancer has better prognosis in terms of recurrence and
survival compared with macroscopic disease that is left
post-surgically [8]. When a preoperative diagnosis of
extrathyroidal invasion is made, identification and removal
Figure 4 Medium power picture of an H&E stained section of
the parathyroid intraparenchymal metastatic nodule. A higher
magnification picture of the tumor in the affected parathyroid
(50 μm calibrated picture).
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nodes or soft tissue) could be attempted [9], as late and in-
complete resection of cervical disease affects patient sur-
vival in an adverse way.
Parathyroid metastases, unless multiple, have an un-
certain clinical impact on patients, as involvement of
one parathyroid will not alter serum calcium levels if the
other parathyroid glands are functioning appropriately.
This is the first report of parathyroid involvement in
cases of FTC. FTC usually metastasizes at distant sites,
although large tumors may invade local structures [10].
Among the three reported FTC patients, one exhibited
metastatic foci in the parathyroid not related to direct
contact, which may represent a hematogenous spread of
follicular cancer. Blood supply to the parathyroid glands
is mainly derived from the inferior thyroid arteries, and
vein and lymph drainage is also made via thyroid gland
vessels [11]. The local circulation is not well established,
as blood supply in cases of ectopic parathyroid glands
depends on their location [12].
Conclusions
In conclusion, parathyroid involvement in cases with thy-
roid cancer is rare and possibly underestimated. We reportthe first three cases of FTC with parathyroid metastases.
Locally invasive tumors may invade the parathyroid gland,
independent of patient age and tumor size. The clinical
significance of such an event has not yet been answered.
Multicentre studies are needed to define the true inci-
dence, explore the specific characteristics and evolution of
parathyroid metastases, and determine the influence on
disease outcome.
Abbreviations
FTC: follicular thyroid cancer; H&E: hematoxylin and eosin; PTC: papillary
thyroid cancer.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KPP conceived and coordinated the study. SM, PM, PKI, and LM gathered the
data. MB and AC prepared the database and analyzed the data. NF and KM
examined the histological material. SM drafted the tables. KPP and AC wrote
the manuscript. All authors read and approved the final manuscript.
Authors’ information
KPP has great experience in the management of patients with endocrine
malignancies.
Author details
1Department of Endocrinology & Endocrine Oncology, Theagenio Cancer
Hospital, 2 Al Simeonidi street, Thessaloniki 54007, Greece. 2Pathology
Department, General Hospital of Kavala, 65302, Kavala, Greece. 3Pathology
Department, Hippokratio Hospital, Thessaloniki, Greece.
Received: 17 October 2011 Accepted: 1 June 2012
Published: 28 June 2012
References
1. Gattuso P, Khan NA, Jablokow VR, Kathuria S: Neoplasms metastatic
to parathyroid glands. South Med J 1988, 81:1467.
2. de la Monte SM, Hutchins GM, Moore GW: Endocrine organ
metastases from breast carcinoma. Am J Pathol 1984, 114:131–136.
3. Tang W, Kakudo K, Nakamura MY, Nakamura M, Mori I, Morita S,
Miyauchi A: Parathyroid gland involvement by papillary carcinoma
of the thyroid gland. Arch Pathol Lab Med 2002, 126:1511–1514.
4. Ito Y, Kakudo K, Hirokawa M, Fukushima M, Tomoda C, Inoue H, Kihara M,
Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F,
Miyauchi A: Clinical significance of extrathyroid extension to the parathyroid
gland of papillary thyroid carcinoma. Endocr J 2009, 56:251–255.
5. Kakudo K, Tang W, Ito Y, Nakamura Y, Yasuoka H, Morita S, Miyauchi
A: Parathyroid invasion, nodal recurrence, and lung metastasis by
papillary carcinoma of the thyroid. J Clin Pathol 2004, 57:245–249.
6. Pazaitou-Panayiotou K, Kaprara A, Boudina M, Georgiou E, Drimonitis
A, Vainas I, Raptou E, Galaktidou G: Thyroid carcinoma in children
and adolescents: presentation, clinical course, and outcome of
therapy in 23 children and adolescents in Northern Greece.
Hormones (Athens) 2005, 4:213–220.
7. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ,
Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI,
Steward DL, Tuttle RM: Revised American Thyroid Association
management guidelines for patients with thyroid nodules and
differentiated thyroid cancer. Thyroid 2009, 19:1167–1214.
8. Nishida T, Nakao K, Hashimoto T: Local control in differentiated
thyroid carcinoma with extrathyroidal invasion. Am J Surg 2000,
179:86–91.
9. Kowalski LP, Filho JG: Results of the treatment of locally invasive thyroid
carcinoma. Head Neck 2002, 24:340–344.
10. Asari R, Koperek O, Scheuba C, Riss P, Kaserer K, Hoffmann M,
Niederle B: Follicular thyroid carcinoma in an iodine-replete
Chrisoulidou et al. World Journal of Surgical Oncology 2012, 10:121 Page 5 of 5
http://www.wjso.com/content/10/1/121endemic goiter region: a prospectively collected, retrospectively
analyzed clinical trial. Ann Surg 2009, 249:1023–1031.
11. Miller FR: Surgical anatomy of the thyroid and parathyroid glands.
Otolaryngol Clin North Am 2003, 36:1–7. vii.
12. Lane MJ, Desser TS, Weigel RJ, Jeffrey RB Jr: Use of color and power
Doppler sonography to identify feeding arteries associated with
parathyroid adenomas. AJR Am J Roentgenol 1998, 171:819–823.
doi:10.1186/1477-7819-10-121
Cite this article as: Chrisoulidou et al.: Parathyroid involvement in
thyroid cancer: an unforeseen event. World Journal of Surgical Oncology
2012 10:121.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
